Showing results (1-10 of 983) with videos related to

Sort By:
Pageof 99
Cardiovascular Research|August 4, 2022
Cardiovascular effects of incretins: focus on glucagon-like peptide-1 receptor agonistsSten Madsbad, Jens J Holst
The Lancet. Diabetes & Endocrinology|March 14, 2014
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgerySten Madsbad, Carsten Dirksen, Jens J Holst
Current Diabetes Reviews|November 21, 2009
Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonistsUrd Kielgast, Jens J Holst, Sten Madsbad
The Journal of Clinical Endocrinology and Metabolism|March 9, 2010
Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patientsUrd Kielgast, Meena Asmar, Sten Madsbad, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|June 11, 2008
Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trialsSten Madsbad, Thure Krarup, Carolyn F Deacon, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2010
Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?Meena Asmar, Michael Bache, Filip K Knop, et al.
Pageof 99